宁科生物 (600165.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(宁科生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 66,620,576.2955,878,984.2246,109,368.7575,010,260.11130,821,099.97308,585,961.26166,716,293.63
 营业收入(元) 66,620,576.2955,878,984.2246,109,368.7575,010,260.11130,821,099.97308,585,961.26166,716,293.63
二、营业总成本(元) 144,175,129.30138,676,108.34115,018,464.73171,223,142.43170,459,383.53281,946,903.27206,628,217.61
 营业成本(元) 90,052,078.2553,551,240.0471,983,460.4390,690,871.61107,351,664.92241,829,010.11165,574,364.65
 研发费用(元) 4,301,415.632,444,652.173,093,172.862,740,902.526,962,704.208,864,347.836,940,503.40
 营业税金及附加(元) 1,785,678.251,675,912.141,262,867.631,441,806.111,292,854.052,405,933.121,021,432.43
 销售费用(元) 1,481,160.121,256,613.881,290,972.271,376,600.641,733,297.89104,995.442,286,978.37
 管理费用(元) 11,498,027.2541,650,128.8210,843,447.3935,117,268.6034,047,263.2316,315,108.1712,509,727.58
 财务费用(元) 35,056,769.8038,097,561.2926,544,544.1539,855,692.9519,071,599.2412,427,508.6018,295,211.18
  其中:利息费用(元) 39,707,496.7035,624,522.4926,645,156.9139,875,382.5920,566,567.8213,585,022.5417,848,106.18
  其中:利息收入(元) 14,236.9837,753.15120,011.19187,417.58349,165.60144,225.0728,619.77
 资产减值损失(元) -14,127,949.06-2,015,459.93-8,885,378.10-56,510,586.46---
 信用减值损失(元) ----82,820.18---
三、其他经营收益
 加:投资收益(元) 1,559,091.244,393,852.539,675,894.2920,840,027.82781,686.113,227,596.0810,111,150.21
  其中:对联营企业和合营企业的投资收益(元) 1,559,091.244,393,852.539,675,894.2920,722,466.08776,123.953,040,272.849,254,841.41
 资产处置收益(元) 121,578.97-12,080.53-27,076.70-87,378.64---
 其他收益(元) 481,118.691,593,439.971,478,335.89773,275.351,522,686.821,046,867.54535,295.77
四、营业利润(元) -89,520,713.17-78,872,164.04-66,667,320.60-131,280,364.43-37,306,718.2435,909,754.04-29,265,478.00
 加:营业外收入(元) 14,098.86--1.42200,484.04-109,930.931,753,968.42
 减:营业外支出(元) 4,458,481.938,928,309.3171,929.225,497,975.0076,975.538,433.6268,715.86
五、利润总额(元) -93,965,096.24-87,789,384.60-66,739,249.82-136,778,338.01-37,183,209.7335,791,389.49-27,580,225.44
 减:所得税费用(元) -136,743.77-421,618.13-52,993.213,553,972.41-165,197.73646,407.54323,313.83
六、净利润(元) -93,828,352.47-87,367,766.47-66,686,256.61-140,332,310.42-37,018,012.0135,144,981.96-27,903,539.27
(一)按经营持续性分类
  持续经营净利润(元) -93,828,352.47-87,367,766.47-66,686,256.61-140,332,310.42-37,018,012.0135,144,981.96-27,903,539.27
(二)按所有权归属分类
  归属于母公司股东的净利润(元) -83,452,373.33-78,338,919.32-58,433,529.67-120,062,546.71-30,330,418.0131,864,400.80-22,955,758.38
  少数股东损益(元) -10,375,979.14-9,028,847.15-8,252,726.94-20,269,763.71-6,687,594.003,280,581.16-4,947,780.89
 扣除非经常性损益后的净利润(元) -80,470,520.19-72,767,846.06-58,986,587.99-115,154,486.54-31,315,491.2130,909,156.28-24,845,840.13
七、每股收益
 一、基本每股收益(元) -0.12-0.12-0.09-0.18-0.040.05-0.03
 二、稀释每股收益(元) -0.12-0.12-0.09-0.18-0.040.05-0.03
八、其他综合收益(元) 10,607.39-253,891.93274,245.79-76,990.7268,724.0243,557.53190,957.71
 归属于母公司股东的其他综合收益(元) 10,607.39-253,891.93274,245.79-76,990.7268,724.0243,557.53190,957.71
九、综合收益总额(元) -93,817,745.08-87,621,658.40-66,412,010.82-140,409,301.14-36,949,287.9935,188,539.49-27,712,581.56
 归属于母公司所有者的综合收益总额(元) -83,441,765.94-78,592,811.25-58,159,283.88-120,139,537.43-30,261,693.9931,907,958.33-22,764,800.67
 归属于少数股东的综合收益总额(元) -10,375,979.14-9,028,847.15-8,252,726.94-20,269,763.71-6,687,594.003,280,581.16-4,947,780.89
公告日期 2023-10-282023-08-152023-04-292023-04-282022-10-282022-08-102022-04-30
审计意见(境内) 保留意见

前瞻产业研究院